Health Care & Life Sciences » Biotechnology | Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc.

Sarepta Therapeutics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
66.44 M
Public Float
53.91 M
Sarepta Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$5.94
Market Cap
$11.18 B
Shares Outstanding
74.15 M
Public Float
66.53 M

Profile

Address
215 First Street
Cambridge Massachusetts 02142
United States
Employees -
Website http://www.sareptatherapeutics.com
Updated 07/08/2019
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare neuromuscular diseases. It focuses on the development of its potentially disease-modifying Duchenne Muscular Dystrophy drug candidates. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Financials

View All

Douglas S. Ingram
President, Chief Executive Officer & Director
M. Kathleen Behrens
Chairman